Embedding Reflex Biomarker Testing to Advance Precision Lung Cancer Care: Jonathan Thompson, MD, MS
August 18th 2025Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision therapy in lung cancer and to address persistent disparities in timely, equitable access to care.